kidney issues with tirzepatide GLP therapies have established themselves as kidney-protective in type 2 diabetes and high risk of disease. This new post-hoc analysis of SURPASS-CVOT's kidney outcomes shows greater kidney protection (#mounjaro) Tirzepatide and prevention of chronic

In this comprehensive guide, well explore what MCAS is, what causes it, how its diagnosed, and how a functional medicine approach can help restore balance, calm inflammation, and support long-term healing

Read the full article: 5 things doctors want you to know before you start taking a GLP-1 washingtonpost.com To view or add a comment, sign in More Relevant Posts As broader and longer term experience with the use of the modern obesity medications rises, the importance of proper nutrition during therapy has become apparent

No peptide addresses aging in isolation, and the foundation of any protocol matters as much as the peptide itself

References [1] Farrell RJ, Kelly CP

Use of these substances may result in sanctions regardless of their legal status under medicines law

The alteration of GLP-2 (33) might be due to an adoptive response to intestinal injury, which promotes mucosal epithelium restoration in a self-repair mechanism